Zai Lab to Participate in 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 05 2026
0mins
Source: Businesswire
- Conference Participation: Zai Lab will participate in the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, at 3:00 p.m. PST, showcasing its innovative research in oncology, immunology, and other fields, aiming to enhance its visibility in the biopharmaceutical industry.
- Live Webcast: The event will be streamed live on Zai Lab's Investor Relations page, allowing global investors to stay updated on the company's latest developments, which is expected to bolster investor confidence.
- Replay Availability: An archived replay of the presentation will be available for up to 30 days post-event, ensuring that investors who cannot attend live can still access critical information, thereby enhancing transparency.
- Company Background: Zai Lab is an innovative biopharmaceutical company based in China and the U.S., focused on developing products that address significant unmet medical needs, and this conference will further emphasize its strategic positioning in the global biopharmaceutical market.
Analyst Views on 09688
Wall Street analysts forecast 09688 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 09688 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 15.480
Low
Averages
High
Current: 15.480
Low
Averages
High
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
